| ADX Energy Ltd (ADX) ORDINARY FULLY PAID |
Energy |
$23 |
Change of Director's Interest Notice - E Etienvre
|
5 Feb 2026 11:39AM |
$0.031 |
$0.026 |
fallen by
16.13%
|
|
| ADX Energy Ltd (ADX) ORDINARY FULLY PAID |
Energy |
$23 |
Change of Director's Interest Notice - P Fink
|
5 Feb 2026 11:39AM |
$0.031 |
$0.026 |
fallen by
16.13%
|
|
| Lotus Resources Limited (LOT) ORDINARY FULLY PAID |
Energy |
$180 |
Investor Presentation - Equity Raise
|
5 Feb 2026 11:36AM |
$2.880 |
$0.660 |
fallen by
77.08%
|
|
LOT - Price-sensitive ASX Announcement
Full Release
Key Points
- A$76 million equity raising to support Kayelekera project ramp-up.
- Completion of acid plant and grid connection projects scheduled for 2026.
- Funding to address increased sulphuric acid and sulphur costs.
- Strategic growth initiatives include Letlhakane uranium project development.
- Market conditions are favorable due to strong uranium fundamentals.
- Inventory pre-payment facilities under negotiation for additional liquidity.
- Targeting steady-state production at Kayelekera by Q2 CY2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lotus Resources Limited (LOT) ORDINARY FULLY PAID |
Energy |
$180 |
Lotus Launches A$76 million Placement
|
5 Feb 2026 11:35AM |
$2.880 |
$0.660 |
fallen by
77.08%
|
|
LOT - Price-sensitive ASX Announcement
Full Release
Key Points
- Lotus launches A$76 million placement to enhance financial flexibility.
- The placement is non-underwritten and priced at A$2.15 per share.
- A share purchase plan aims to raise an additional A$5 million.
- Funds will support the ramp-up to steady-state production and positive cash flow.
- First product shipment expected in Q2 CY2026.
- Offer price is at a 25.3% discount to the last closing price.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| KKR Credit Income Fund (KKC) ORDINARY UNITS FULLY PAID |
Financials |
$668 |
Net Tangible Asset Backing
|
5 Feb 2026 11:31AM |
$2.240 |
$2.070 |
fallen by
7.59%
|
|
| Vertex Minerals Limited (VTX) ORDINARY FULLY PAID |
Materials |
$29 |
Ore Production Update, Reward Gold Mine
|
5 Feb 2026 11:30AM |
$0.225 |
$0.100 |
fallen by
55.56%
|
|
| Loftus Peak Global Disruption Hedged Active ETF (LPHD) |
Financials |
$129 |
Unitholder Monthly Report for January 2026
|
5 Feb 2026 11:27AM |
$8.960 |
$10.420 |
risen by
16.29%
|
|
| European Lithium Limited (EUR) ORDINARY FULLY PAID |
Materials |
$613 |
EUR sells 2.5m CRML Shares for approximately $A45m
|
5 Feb 2026 11:15AM |
$0.230 |
$0.355 |
risen by
54.35%
|
|
EUR - Price-sensitive ASX Announcement
Full Release
Key Points
- European Lithium sold 2.5 million CRML shares for A$45 million.
- The sale boosts cash reserves to approximately A$356 million.
- European Lithium retains 45,536,338 CRML shares.
- Remaining CRML shares valued at US$689,420,157.
- No plans for further CRML share sales in the next four months.
- Maintains strategic influence for potential corporate transactions.
- European Lithium focuses on lithium and titanium assets.
- Operations in Austria, Ukraine, Ireland, and other locations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| SRG Global Limited (SRG) ORDINARY FULLY PAID |
Industrials |
$2,243 |
Advance Notice - Half-Year Results Investor Briefing
|
5 Feb 2026 11:13AM |
$3.030 |
$3.580 |
risen by
18.15%
|
|
| ResMed Inc. (RMD) CDI 10:1 FOREIGN EXEMPT NYSE |
Health Care |
$17,838 |
Statement of CDIs on issue - RMD
|
5 Feb 2026 11:12AM |
$35.710 |
$30.030 |
fallen by
15.91%
|
|
| Epsilon Healthcare Limited (EPN) ORDINARY FULLY PAID |
Health Care |
$9 |
Epsilon Pharma signs manufacturing agreement with Puro NZ
|
5 Feb 2026 11:11AM |
$0.030 |
$0.022 |
fallen by
26.67%
|
|
EPN - Price-sensitive ASX Announcement
Full Release
Key Points
- Epsilon Pharma signs a manufacturing agreement with Puro NZ.
- Initial focus on exporting to the UK, expanding to Europe.
- Epsilon to leverage EU GMP certifications and manufacturing capabilities.
- Expected revenue of AU $6 million over three years.
- Partnership enhances Epsilon's global competitive position in healthcare.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Venari Minerals NL (VMS) ORDINARY FULLY PAID |
Materials |
$10 |
Red Mountain Lithium Project - Market Presentation
|
5 Feb 2026 11:07AM |
$0.200 |
$0.090 |
fallen by
55%
|
|
| Red Mountain Mining Limited (RMX) ORDINARY FULLY PAID |
Materials |
$13 |
ACQUISITION OF HIGH-GRADE ANTIMONY PROJECT AT THOMPSON FALLS
|
5 Feb 2026 11:00AM |
$0.025 |
$0.012 |
fallen by
52%
|
|
RMX - Price-sensitive ASX Announcement
Full Release
Key Points
- Red Mountain Mining Limited (ASX: RMX) has acquired the Thompson Falls Antimony Project.
- The project is located near the United States Antimony Corporation's operations, which includes the only antimony smelter in the US.
- Initial assays from the project have shown high-grade results, with up to 36.5% antimony and 0.65g/t gold.
- The project is strategically positioned at the eastern end of Idaho's Coeur d'Alene mineral district, a significant silver and antimony production area.
- Red Mountain Mining aims to leverage the project as part of their critical minerals portfolio, benefiting from US and Australian government support.
- The acquisition further strengthens Red Mountain's presence in Tier-1 mining districts in the US, alongside other projects in Utah and Idaho.
- The US Government has launched a strategic minerals stockpile initiative, placing emphasis on securing critical mineral supply chains, including antimony.
- Red Mountain intends to continue exploration and sampling in the Thompson Falls area to identify further mineralized zones.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Greenwing Resources Ltd (GW1) ORDINARY FULLY PAID |
Materials |
$36 |
Updated Strategy For Que River Project
|
5 Feb 2026 10:50AM |
$0.045 |
$0.069 |
risen by
53.33%
|
|
GW1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Greenwing Resources Ltd plans a two-stage development strategy for Que River.
- Stage 1 focuses on mining polymetallic ores, supported by strong metal prices.
- Potential for Que River to host digital infrastructure is being assessed.
- Existing infrastructure includes a 30MW substation and 200ML of water.
- Que River site offers a cool climate and secure, remote location.
- Preliminary discussions held with strategic partners and government departments.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Gale Pacific Limited (GAP) ORDINARY FULLY PAID |
Consumer Discretionary |
$23 |
Notification of cessation of securities - GAP
|
5 Feb 2026 10:48AM |
$0.091 |
$0.081 |
fallen by
10.99%
|
|
| JPMorgan Climate Change Solutions Active ETF (Managed Fund) (T3MP) |
Financials |
$3 |
Notional Derivative Exposure
|
5 Feb 2026 10:36AM |
$70.520 |
$77.240 |
risen by
9.53%
|
|
| JPMorgan Global Research Enhanced Index Equity Active ETF (Managed Fund) (JREG) |
Financials |
$66 |
Notional Derivative Exposure
|
5 Feb 2026 10:35AM |
$81.840 |
$86.870 |
risen by
6.15%
|
|
| JPMorgan Global Research Enhanced Index Equity Active ETF (Managed Fund) (Hedged) (JRHG) |
Financials |
$25 |
Notional Derivative Exposure
|
5 Feb 2026 10:35AM |
$74.320 |
$73.710 |
fallen by
0.82%
|
|
| JPMorgan US 100Q Equity Premium Income Active ETF (Managed Fund) (JPEQ) |
Financials |
$92 |
Notional Derivative Exposure
|
5 Feb 2026 10:35AM |
$59.430 |
$61.500 |
risen by
3.48%
|
|
| JPMorgan US 100Q Equity Premium Income Active ETF (Managed Fund) (Hedged) (JPHQ) |
Financials |
$12 |
Notional Derivative Exposure
|
5 Feb 2026 10:35AM |
$60.750 |
$56.480 |
fallen by
7.03%
|
|
| Zenith Minerals Limited (ZNC) ORDINARY FULLY PAID |
Materials |
$55 |
Unmarketable Share Sale Facility Completed
|
5 Feb 2026 10:34AM |
$0.095 |
$0.088 |
fallen by
7.37%
|
|
| JPMorgan Global Select Equity (Hedged) Active ETF (JHLO) |
Financials |
$5 |
Notional Derivative Exposure
|
5 Feb 2026 10:33AM |
$60.150 |
$59.520 |
fallen by
1.05%
|
|
| JPMorgan Global Select Equity Active ETF (JGLO) |
Financials |
$7 |
Notional Derivative Exposure
|
5 Feb 2026 10:33AM |
$57.710 |
$59.570 |
risen by
3.22%
|
|
| JPMorgan Equity Premium Income Active ETF (Managed Fund) (Hedged) (JHPI) |
Financials |
$8 |
Notional Derivative Exposure
|
5 Feb 2026 10:32AM |
$51.880 |
$45.500 |
fallen by
12.30%
|
|
| JPMorgan Equity Premium Income Active ETF (Managed Fund) (JEPI) |
Financials |
$159 |
Notional Derivative Exposure
|
5 Feb 2026 10:32AM |
$50.290 |
$49.020 |
fallen by
2.53%
|
|